Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Other Non-Current Liabilities: 2024-2025

Historic Other Non-Current Liabilities for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to $3.0 million.

  • Kura Oncology's Other Non-Current Liabilities rose 102.65% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year increase of 102.65%. This contributed to the annual value of $1.8 million for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Kura Oncology's Other Non-Current Liabilities is $3.0 million, which was up 14.87% from $2.6 million recorded in Q2 2025.
  • In the past 5 years, Kura Oncology's Other Non-Current Liabilities registered a high of $3.0 million during Q3 2025, and its lowest value of $951,000 during Q1 2024.